Target intelligence / Profile preview

Spectrin beta chain, non-erythrocytic 5 (SPTBN5)

Target
SPTBN5
Molecular classification
Other (cytoskeletal protein), Structural protein (Spectrin family)
01

Overview

Spectrin beta chain, non-erythrocytic 5 (SPTBN5) is a large cytoskeletal protein encoded by the SPTBN5 gene on chromosome 15q15.1, containing 68 exons and producing a 3674-amino acid protein[1][2][3]. It is a member of the spectrin family responsible for linking membrane proteins and lipids to the actin cytoskeleton, thereby contributing to cell shape, mechanical stability, and intracellular transport[1][2][3]. SPTBN5 forms oligomers with alpha-spectrin and contains calponin homology domains (actin binding), spectrin repeats (flexibility and self-association), and a C-terminal pleckstrin homology domain (membrane recruitment)[1][3]. It is ubiquitously expressed, with significant roles in the brain and other organs[1]. Recent genetic data link biallelic SPTBN5 loss-of-function mutations to a syndrome characterized by intellectual disability, developmental delay, seizures, and, variably, aggressive behavior and mild dysmorphic features[1]. Other family members of spectrin are implicated in erythroid and neurological disorders, but SPTBN5 currently lacks therapeutic targeting or confirmed drug interactions[1][2].

Other names
Spectrin beta, non-erythrocytic 5SPTBN5BSPECVHUBSPECVHUSPECVBeta-V spectrinbeta V spectrinspectrin beta chain, non-erythrocytic 5spectrin beta chain, brain 4spectrin, non-erythroid beta chain 4
02

Biological functions

Cytoskeletal organizationMembrane stabilityActin bindingGolgi and lysosomal transportCellular morphology maintenance
03

Disease associations

Neurodevelopmental disease (Intellectual disability, developmental delay, seizures)Other (no strong evidence for cancer, inflammation, neurodegenerative, or cardiovascular disease roles reported)

Beyond the preview

Go deeper on Spectrin beta chain, non-erythrocytic 5 (SPTBN5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spectrin beta chain, non-erythrocytic 5 (SPTBN5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call